STERIS EBITDA Margin 2012-2026 | STE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for STERIS (STE) over the last 10 years. The current EBITDA margin for STERIS as of March 31, 2026 is .
| STERIS EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $5.83B | $1.49B | 25.50% |
| 2025-09-30 | $5.70B | $1.46B | 25.64% |
| 2025-06-30 | $5.57B | $1.41B | 25.29% |
| 2025-03-31 | $5.46B | $1.34B | 24.57% |
| 2024-12-31 | $5.40B | $1.36B | 25.17% |
| 2024-09-30 | $5.33B | $1.36B | 25.54% |
| 2024-06-30 | $5.24B | $1.37B | 26.15% |
| 2024-03-31 | $5.14B | $1.41B | 27.38% |
| 2023-12-31 | $4.68B | $1.46B | 31.12% |
| 2023-09-30 | $4.60B | $1.41B | 30.74% |
| 2023-06-30 | $4.56B | $1.39B | 30.48% |
| 2023-03-31 | $4.54B | $1.35B | 29.81% |
| 2022-12-31 | $4.42B | $1.31B | 29.51% |
| 2022-09-30 | $4.42B | $1.30B | 29.40% |
| 2022-06-30 | $4.41B | $1.30B | 29.40% |
| 2022-03-31 | $4.22B | $1.10B | 26.00% |
| 2021-12-31 | $4.25B | $0.94B | 22.20% |
| 2021-09-30 | $3.85B | $0.83B | 21.44% |
| 2021-06-30 | $3.41B | $0.70B | 20.58% |
| 2021-03-31 | $3.11B | $0.77B | 24.71% |
| 2020-12-31 | $3.06B | $0.77B | 25.32% |
| 2020-09-30 | $3.02B | $0.76B | 25.22% |
| 2020-06-30 | $3.00B | $0.74B | 24.71% |
| 2020-03-31 | $3.03B | $0.73B | 24.22% |
| 2019-12-31 | $2.98B | $0.72B | 24.06% |
| 2019-09-30 | $2.90B | $0.68B | 23.33% |
| 2019-06-30 | $2.84B | $0.65B | 22.99% |
| 2019-03-31 | $2.78B | $0.64B | 22.90% |
| 2018-12-31 | $2.73B | $0.60B | 22.09% |
| 2018-09-30 | $2.70B | $0.60B | 22.22% |
| 2018-06-30 | $2.65B | $0.59B | 22.26% |
| 2018-03-31 | $2.62B | $0.58B | 22.06% |
| 2017-12-31 | $2.59B | $0.53B | 20.54% |
| 2017-09-30 | $2.57B | $0.50B | 19.42% |
| 2017-06-30 | $2.58B | $0.48B | 18.40% |
| 2017-03-31 | $2.61B | $0.47B | 18.11% |
| 2016-12-31 | $2.62B | $0.52B | 19.65% |
| 2016-09-30 | $2.59B | $0.49B | 18.94% |
| 2016-06-30 | $2.44B | $0.42B | 17.11% |
| 2016-03-31 | $2.24B | $0.36B | 15.94% |
| 2015-12-31 | $2.05B | $0.30B | 14.38% |
| 2015-09-30 | $1.91B | $0.29B | 15.01% |
| 2015-06-30 | $1.88B | $0.32B | 17.09% |
| 2015-03-31 | $1.85B | $0.32B | 17.23% |
| 2014-12-31 | $1.81B | $0.31B | 17.03% |
| 2014-09-30 | $1.75B | $0.30B | 17.23% |
| 2014-06-30 | $1.67B | $0.29B | 17.27% |
| 2014-03-31 | $1.62B | $0.28B | 17.38% |
| 2013-12-31 | $1.59B | $0.29B | 18.16% |
| 2013-09-30 | $1.56B | $0.30B | 19.10% |
| 2013-06-30 | $1.53B | $0.31B | 20.10% |
| 2013-03-31 | $1.50B | $0.31B | 20.79% |
| 2012-12-31 | $1.46B | $0.32B | 21.67% |
| 2012-09-30 | $1.44B | $0.30B | 21.00% |
| 2012-06-30 | $1.43B | $0.29B | 20.14% |
| 2012-03-31 | $1.41B | $0.29B | 20.26% |
| 2011-12-31 | $1.40B | $0.27B | 19.07% |
| 2011-09-30 | $1.37B | $0.25B | 17.91% |
| 2011-06-30 | $1.34B | $0.25B | 18.70% |
| 2011-03-31 | $1.21B | $0.14B | 11.52% |
| 2010-12-31 | $1.16B | $0.13B | 11.46% |
| 2010-09-30 | $1.16B | $0.16B | 13.61% |
| 2010-06-30 | $1.16B | $0.15B | 13.24% |
| 2010-03-31 | $1.26B | $0.26B | 20.75% |
| 2009-12-31 | $1.27B | $0.26B | 20.31% |
| 2009-09-30 | $1.26B | $0.25B | 19.59% |
| 2009-06-30 | $1.27B | $0.24B | 19.21% |
| 2009-03-31 | $1.30B | $0.24B | 18.26% |
| 2008-12-31 | $1.33B | $0.24B | 18.36% |
| 2008-09-30 | $1.32B | $0.23B | 17.45% |
| 2008-06-30 | $1.30B | $0.21B | 16.44% |
| 2008-03-31 | $1.27B | $0.20B | 15.97% |
| 2007-12-31 | $1.24B | $0.20B | 16.21% |
| 2007-09-30 | $1.23B | $0.20B | 16.57% |
| 2007-06-30 | $1.21B | $0.20B | 16.64% |
| 2007-03-31 | $1.20B | $0.20B | 17.03% |
| 2006-12-31 | $1.18B | $0.20B | 16.54% |
| 2006-09-30 | $1.17B | $0.20B | 16.80% |
| 2006-06-30 | $1.16B | $0.19B | 16.78% |
| 2006-03-31 | $1.16B | $0.19B | 16.65% |
| 2005-12-31 | $1.12B | $0.19B | 17.11% |
| 2005-09-30 | $1.10B | $0.19B | 17.23% |
| 2005-06-30 | $1.10B | $0.19B | 17.63% |
| 2005-03-31 | $1.08B | $0.19B | 17.84% |
| 2004-12-31 | $1.04B | $0.18B | 17.39% |
| 2004-09-30 | $1.04B | $0.18B | 17.20% |
| 2004-06-30 | $1.03B | $0.18B | 17.53% |
| 2004-03-31 | $1.03B | $0.18B | 17.26% |
| 2003-12-31 | $1.06B | $0.19B | 17.58% |
| 2003-09-30 | $1.03B | $0.18B | 17.60% |
| 2003-06-30 | $1.01B | $0.18B | 17.62% |
| 2003-03-31 | $0.97B | $0.17B | 17.70% |
| 2002-12-31 | $0.94B | $0.16B | 16.97% |
| 2002-09-30 | $0.92B | $0.15B | 16.34% |
| 2002-06-30 | $0.89B | $0.14B | 15.49% |
| 2002-03-31 | $0.87B | $0.13B | 14.76% |
| 2001-12-31 | $0.84B | $0.08B | 9.51% |
| 2001-09-30 | $0.83B | $0.08B | 9.44% |
| 2001-06-30 | $0.81B | $0.08B | 9.35% |
| 2001-03-31 | $0.80B | $0.07B | 8.88% |
| 2000-12-31 | $0.77B | $0.05B | 6.74% |
| 2000-09-30 | $0.76B | $0.05B | 6.43% |
| 2000-06-30 | $0.77B | $0.06B | 7.55% |
| 2000-03-31 | $0.76B | $0.07B | 9.07% |
| 1999-12-31 | $0.80B | $0.14B | 17.79% |
| 1999-09-30 | $0.81B | $0.16B | 19.78% |
| 1999-06-30 | $0.80B | $0.17B | 20.60% |
| 1999-03-31 | $0.80B | $0.17B | 21.30% |
| 1998-12-31 | $0.78B | $0.17B | 21.26% |
| 1998-09-30 | $0.76B | $0.16B | 20.48% |
| 1998-06-30 | $0.74B | $0.15B | 19.62% |
| 1998-03-31 | $0.72B | $0.14B | 18.89% |
| 1997-12-31 | $0.69B | $0.12B | 18.10% |
| 1997-09-30 | $0.65B | $0.11B | 17.26% |
| 1997-06-30 | $0.61B | $0.10B | 16.94% |
| 1997-03-31 | $0.59B | $0.10B | 17.21% |
| 1996-12-31 | $0.44B | $0.08B | 17.61% |
| 1996-09-30 | $0.32B | $0.06B | 18.35% |
| 1996-06-30 | $0.31B | $0.15B | 48.39% |
| 1996-03-31 | $0.20B | $0.13B | 65.84% |
| 1995-12-31 | $0.20B | $0.13B | 65.82% |
| 1995-09-30 | $0.19B | $0.13B | 67.20% |
| 1995-06-30 | $0.07B | $0.02B | 20.83% |
| 1995-03-31 | $0.07B | $0.01B | 21.54% |
| 1994-12-31 | $0.06B | $0.01B | 22.03% |
| 1994-09-30 | $0.05B | $0.01B | 20.37% |
| 1994-06-30 | $0.05B | $0.01B | 20.41% |
| 1994-03-31 | $0.05B | $0.01B | 17.78% |
| 1993-12-31 | $0.04B | $0.01B | 15.00% |
| 1993-09-30 | $0.04B | $0.01B | 14.29% |
| 1993-06-30 | $0.03B | $0.00B | 9.68% |
| 1993-03-31 | $0.03B | $0.00B | 7.41% |
| 1992-12-31 | $0.02B | $0.01B | 26.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.830B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |